ENDS Public Health: Difference between revisions

(3 intermediate revisions by 2 users not shown)

Line 223:

=Never Smokers=

=== 2024: [https://www.nature.com/articles/s41598-024-80221-8 Respiratory symptoms among e-cigarette users without an established smoking history in the VERITAS cohort] ===

* First results of VERITAS showing very small differences between non vapers and never use controls. The difference between the two groups is ‘not clinically significant’.

=== 2024: [https://pubmed.ncbi.nlm.nih.gov/38546715/ A Global Health Survey of People Who Vape but Never Smoked: Protocol for the VERITAS (Vaping Effects: Real-World International Surveillance) Study] ===

Line 331:

Line 335:

=Weight=

===2024 Article [https://web.archive.org/web/20241204102835/https://tobaccoreporter.com/2024/12/03/slim-chances/ Harm reduction, smoking cessation and weight]===

*"Nicotine influences eating and weight in multiple ways, from hormones to microbiomes to taste perceptions. The bottom line: Nicotine raises the metabolic rate while also depressing appetite."

===2018: [https://pubmed.ncbi.nlm.nih.gov/29570695/ Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users]===

Line 347:

Line 353:

===See Also===

*[[https://safernicotine.wiki/mediawiki/index.php/Nicotine_therapeutic_benefits#Weight_Loss_.2F_Appetite_Control_.2F_Metabolism_.2F_Obesity|Weight Weight: Nicotine Therapeutic Benefits]]

=PAGE EDITORS - Please only add Studies, Surveys, Papers in this format to keep page organized=

Line 364:

Line 368:

=Suggested studies to add to this page=

=== 2024: [https://tobaccocontrol.bmj.com/content/tobaccocontrol/early/2024/10/29/tc-2024-058734.full.pdf?ijkey=SyCpuy6lOVfmORB&keytype=ref Transformation of the tobacco product market in Japan, 2011–2023] ===

* This paper updates the prior analysis to include trends in the sale of cigarettes and HTPs from 2019 to 2023 and shows that between 2011 and 2023, per capita and total cigarette sales in Japan declined by over 50%. The decline in cigarette sales was minimal from 2011 to 2015 but increased markedly after 2015 following the introduction of HTPs.

* Halving the cigarette market in Japan in just over a decade is a remarkable achievement and figuring out how to replicate this type of change elsewhere should be a priority for public health research. Clinical trials are needed to test if HTPs can help addicted cigarette smokers transition away from smoking

* K Michael Cummings, Avery Roberson, David T Levy , Rafael Meza, Kenneth E Warner, Geoffrey T Fong, Steve Shaowei Xu, Shannon Gravely, Bibha Dhungel, Ron Borland, Richard J O’Connor, Maciej Lukasz Goniewicz, David T Sweanor DOI: 10.1136/tc-2024-058734

[[File:Data reliability.png|alt=The data reliability pyramid. Shows the quality of various data from expert opinion at the bottom to systematic review at the top (lowest quality at bottom, highest at top)|center|frame|The data reliability pyramid]]

@@ Line 223: / Line 223: @@
 =Never Smokers=
+=== 2024: [https://www.nature.com/articles/s41598-024-80221-8 Respiratory symptoms among e-cigarette users without an established smoking history in the VERITAS cohort] ===
+* First results of VERITAS showing very small differences between non vapers and never use controls. The difference between the two groups is ‘not clinically significant’.
 === 2024: [https://pubmed.ncbi.nlm.nih.gov/38546715/ A Global Health Survey of People Who Vape but Never Smoked: Protocol for the VERITAS (Vaping Effects: Real-World International Surveillance) Study] ===
@@ Line 331: / Line 335: @@
 =Weight=
+===2024 Article [https://web.archive.org/web/20241204102835/https://tobaccoreporter.com/2024/12/03/slim-chances/ Harm reduction, smoking cessation and weight]===
+*"Nicotine influences eating and weight in multiple ways, from hormones to microbiomes to taste perceptions. The bottom line: Nicotine raises the metabolic rate while also depressing appetite."
 ===2018: [https://pubmed.ncbi.nlm.nih.gov/29570695/ Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users]===
@@ Line 347: / Line 353: @@
 ===See Also===
 *[[https://safernicotine.wiki/mediawiki/index.php/Nicotine_therapeutic_benefits#Weight_Loss_.2F_Appetite_Control_.2F_Metabolism_.2F_Obesity|Weight Weight: Nicotine Therapeutic Benefits]]
 =PAGE EDITORS - Please only add Studies, Surveys, Papers in this format to keep page organized=
@@ Line 364: / Line 368: @@
 =Suggested studies to add to this page=
+=== 2024: [https://tobaccocontrol.bmj.com/content/tobaccocontrol/early/2024/10/29/tc-2024-058734.full.pdf?ijkey=SyCpuy6lOVfmORB&keytype=ref Transformation of the tobacco product market in Japan, 2011–2023] ===
+* This paper updates the prior analysis to include trends in the sale of cigarettes and HTPs from 2019 to 2023 and shows that between 2011 and 2023, per capita and total cigarette sales in Japan declined by over 50%. The decline in cigarette sales was minimal from 2011 to 2015 but increased markedly after 2015 following the introduction of HTPs.
+* Halving the cigarette market in Japan in just over a decade is a remarkable achievement and figuring out how to replicate this type of change elsewhere should be a priority for public health research. Clinical trials are needed to test if HTPs can help addicted cigarette smokers transition away from smoking
+* K Michael Cummings, Avery Roberson, David T Levy , Rafael Meza, Kenneth E Warner, Geoffrey T Fong, Steve Shaowei Xu, Shannon Gravely, Bibha Dhungel, Ron Borland, Richard J O’Connor, Maciej Lukasz Goniewicz, David T Sweanor DOI: 10.1136/tc-2024-058734
 [[File:Data reliability.png|alt=The data reliability pyramid. Shows the quality of various data from expert opinion at the bottom to systematic review at the top (lowest quality at bottom, highest at top)|center|frame|The data reliability pyramid]]